Fund HoldingsFairmount Funds Management LLC

Total Portfolio Value
$917.39M
Total Bought
$164.61M
Total Sold
$350.18M
Net Transaction
-$185.57M
Filing Period:
Securities
SharesValue ($K)
Q4 2023
Q1 2024
Change
Q4 2023
Q1 2024
Weight (%)
Change
DIANTHUS THERAPEUTICS INC(DNTH)1,928,5032,762,837+834,33420,05682,8859.03%+62,829
APOGEE THERAPEUTICS INC(APGE)2,941,1762,048,647-892,52982,176136,13314.84%+53,956
PROTAGONIST THERAPEUTICS INC0931,890+931,890026,9602.94%+26,960
ENLIVEN THERAPEUTICS INC2,131,3693,202,798+1,071,42929,49856,3376.14%+26,839
ASTRIA THERAPEUTICS INC3,554,1293,554,129027,29650,0245.45%+22,729
GERON CORP(GERN)06,666,667+6,666,667022,0002.40%+22,000
KINIKSA PHARMACEUTICALS LTD2,883,2213,204,841+321,62050,57263,2326.89%+12,660
MERUS N V717,254717,254019,72432,2983.52%+12,573
COGENT BIOSCIENCES INC(COGT)3,558,9754,725,641+1,166,66620,92731,7563.46%+10,830
SPYRE THERAPEUTICS INC(SYRE)378,421378,42108,14414,3541.56%+6,210
TYRA BIOSCIENCES INC(TYRA)1,393,3291,393,329019,29822,8512.49%+3,553
NUVALENT INC(NUVL)1,924,6261,924,6260141,633144,52015.75%+2,887
VIRIDIAN THERAPEUTICS INC(VRDN)1,369,6231,845,813+476,19029,83032,3203.52%+2,490
AXSOME THERAPEUTICS INC(AXSM)2,360,0772,360,0770187,839188,33420.53%+496
TERNS PHARMACEUTICALS INC2,040,0002,040,000013,24013,3821.46%+143
ARGENX SE(ARGX)112,9030-112,90342,9520-42,952
RAYZEBIO INC1,245,9290-1,245,92977,4590-77,459
IMMUNOGEN INC5,929,5920-5,929,592175,8120-175,812
Page 1 of 1